Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement

被引：18

作者：

Levit, Laura A. ^{[1
]}

Perez, Raymond P. ^{[2
]}

Smith, David C. ^{[3
]}

Schilsky, Richard L. ^{[1
]}

Hayes, Daniel F. ^{[3
]}

Vose, Julie M. ^{[4
]}

机构：

[1] Amer Soc Clin Oncol, 2318 Mill Rd, Alexandria, VA 22314 USA

[2] Bristol Myers Squibb, Lawrence Township, NJ USA

[3] Univ Michigan, Ann Arbor, MI 48109 USA

[4] Univ Nebraska Med Ctr, Omaha, NE USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期

关键词：

DRUG SAFETY REPORTS; TRIALS; CANCER; SPONSORS; QUALITY; RULE; IND; FDA;

D O I：

10.1200/JCO.2017.75.8193

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：617 / +

页数：9

共 30 条

[1]

[Anonymous], CTTI IND SAF ADV PRO

[2] Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application [J].

Archdeacon, Patrick ;

Grandinetti, Cheryl ;

Vega, Jose M. ;

Balderson, David ;

Kramer, Judith M. .

THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (02) :200-207

[3] Reporting of Serious Adverse Events During Cancer Clinical Trials to the Institutional Review Board: An Evaluation by the Research on Adverse Drug Events And Reports (RADAR) Project [J].

Belknap, S. M. ;

Georgopoulos, C. H. ;

Lagman, J. ;

Weitzman, S. A. ;

Qualkenbush, L. ;

Yarnold, P. R. ;

Edwards, B. J. ;

McKoy, J. M. ;

Trifilio, S. M. ;

West, D. P. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12) :1334-1340

[4] Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs [J].

Belknap, S. M. ;

Georgopoulos, C. H. ;

West, D. P. ;

Yarnold, P. R. ;

Kelly, W. N. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) :231-236

[5] The Feasibility, Perceived Satisfaction, and Value of Using Synchronous Webinars to Educate Clinical Research Professionals on Reporting Adverse Events in Clinical Trials: A Report From the Children's Oncology Group [J].

Borgerson, Dawn ;

Dino, Jennifer .

JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2012, 29 (06) :316-322

[6]

Clinical Trials Transformation Initiative, PROJ SAF REP

[7]

Clinical Trials Transformation Initiative, CAS STUD EXP IND SAF

[8] Quality of serious adverse events reporting to academic sponsors of clinical trials: far from optimal [J].

Crepin, Sabrina ;

Villeneuve, Claire ;

Merle, Louis .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (06) :719-724

[9]

Delgra CJ:, 2017, WORLD DRUG SAF C AM

[10]

Delgra CJ, 2016, PHARM FIN RUL SUMM I

← 1 2 3 →